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Abstract 
Malaria, a form of P.Falcifarum, is an infectious disease which is often occurred in Indonesia. Mefloquine as a 
synthetic drug with anti-malarial activity is selective inhibitor with lactate dehydrogenase mechanism. Inhibition of 
glycolysis is needed for cell survival. Meanwhile, gallocatecin is kind of flavonoids contained in tea leaves extract 
(Camellia sinensis). The aim of this study is to find natural compounds having potential as anti-malarial agents which 
are more potential than mefloquine. Based on molecular docking, gallocatecin has more anti-malaria activity potent 
than mefloquine. 
Preparation starts with performing molecular docking with PLANTS. Ligand preparation is applied using 
MarvinSketch by drawing gallocatecin compound and then optimize it. Protein preparation is applied by using 
YASARA program. Removing docking protocol (including water if essential) is not required. After all of preparation 
is completed, docking PLANTS is applied. Decrease in score indicates bond stability with protein. 
Gallocatecin compound has an energy of (-95.396), smaller than mefloquine (-71,4036) to bind to 1CET. Thus, it can 
be concluded that gallocatecin has antimicrobial activity which is more potential than mefloquine. Based on 
computation, gallocatecin has strong binding to lactatedehydrogenase. 
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1. Introduction 
*Malaria is one of the dangerous diseases in the world. Malaria is an infectious disease with periodic fever 
caused by the parasite Plasmodium and transmitted by certain kind of mosquitoes called Anopheles. 
Malaria can infect humans, birds, monkeys and other primates, reptiles and rodents. Symptoms of malaria 
include fever, chills, sweating and may be accompanied by other symptoms such as headache, nausea and 
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vomiting. Human body is nest for plasmodium to breed (asexual cycle). Meanwhile, the Anopheles 
mosquito is a vector or definitive nest [2]. There are many synthetic drugs as malaria treat or as an anti-
malarial, for example, mefloquine. It is inhibiting lactatdehidrogenase that serves to compete with NADH 
as a cofactor on NADH bindingsite of the enzyme. Inhibitory lactatdehydrogenase of cofactor enzyme 
causes an inactive function of energy production in plasmodium body [1]. However, mefloquine as 
synthesis drug has several side effects, namely diarrhea, dizziness, headache, vomiting, etc. It requires 
innovative and potential anti-malarial compounds with fewer side effects. Tea leaf extract contains a kind 
of flavonoids called gallocatecin [8]. Structurally, gallocatecin has similarities with synthetic drugs such 
as mefloquine, pamakuin (have a double cyclic). Approximately 40% of gallocatecin contained in green 
tea leaf extract. It means that gallocatecin is easy to be obtained in large quantities. 
 
 
Fig. 1. (a) The structure of mefloquine; (b) The structure of gallocatecin 
Docking molecular is a method for predicting ligand required to the receptor [3]. Docking molecules are 
using receptors and ligands contained in a PDB. It is crystal structure in form of a protein or receptor. 
Protein that plays role in anti-malarial activity is lactate dehydrogenase lCT. It has NADH bindingsite. 
ATP has crystal structure of 1CET bindingsite. Activity determination is based on docking score. 
Decrease in docking score indicates that bindingly, molecules are more stable to the receptor [4][5]. There 
are many docking tools which is frequently applied, for example PLANTS, GOLD, MOE, etc. [7] 
1. 1. Mefloquine Binds In the Cofactor Binding Site of Plasmodium Falciparum Lactate Dehydrogenase 
Mefloquine competes with NADH for binding into the enzyme, acting as a competitive inhibitor for 
this criticalglycolytic enzyme. The specific drug interactions and unique amino acids of enzyme form of 
malaria imply selective binding. Inhibition studies confirm mefloquine that acts as weak inhibitor of 
lactate dehydrogenase, with mild selectivity for the parasite enzyme [11]. Mefloquine has been shown to 
accumulate to mill molar concentrations within the food vacuole in the gut of the parasite, even low levels 
of inhibition may contribute to the biological effectiveness of the drug. The structure of this enzyme-
inhibitor complex provides a template from which the quinoline moiety might be modified to develop 
more efficient inhibitors of the enzyme [9]. 
 
1. 2. Substrate and Cofactor Specification and Selective Inhibition of Lactate Dehydrogenase from 
Malarial Parasite P. Falciparum. 
Lactate dehydrogenase of malarial parasite Plasmodium Falciparum has many amino acid residues. It 
is unique, compared with any other known lactate dehydrogenase. It includes residues that define 
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substrate and cofactor bindingsites. However, lactate dehydrogenase parasite shows high specification of 
pyruvic acid, even more restricted than the specificity of M4 and H4 human lactate dehydrogenase. 
Parasite lactate dehydrogenase shows high catalytic efficiency in the reduction of pyruvate. Parasite 
lactate dehydrogenase also shows similar cofactor specificity to human isoforms in L-lactate oxidation 
with NAD + and with a series of NAD + analogs, suggesting a similar cofactor binding environment in 
spite of  amino acid numerous differences [12]. Parasite lactate dehydrogenase shows an enhanced kcat 
with the analog 3-acetylpyridine adenine dinucleotide (apad +), while the human isoforms shows lower 
kcat. This differential response to apad + provides the kinetic basis for the enzyme-based detection of 
malarial parasites. A series of inhibitors structurally related to the natural product gossypol are shown to 
be competitive inhibitors of the binding of NADH. Insignificant changes in structure produce marked 
changes in selectivity of inhibition of lactate dehydrogenase. 7-p-Trifluoromethylbenzyl-8-
deoxyhemigossylic acid inhibited parasite lactate dehydrogenase, which is 65 - and 400-fold tighter 
binding compared to the M4 and H4 isoforms of human lactate dehydrogenase [10]. The results suggest 
that cofactor site of parasite lactate dehydrogenase may be potential targets for structure-based drug 
design [2]. 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2. The structure of  lactate dehydrogenase 
 
2. Docking Molecular 
Molecular docking is in-silico simulation procedure to predict conformation of receptor-ligand 
complex, where the receptor is frequently in protein or nucleic acid molecule (DNA or RNA) and the 
ligand is either a small molecule or another protein. It can also be defined as a simulation process where a 
ligand position is estimated in a predicted or pre-defined bindingsite [19]. Molecular docking simulations 
may be applied for reproducing experimental data through docking validations algorithms, where protein-
ligand or protein conformations are obtained in-silico and compared to structures obtained from X-ray 
crystallography or nuclear magnetic resonance. Furthermore, docking is one of main tools for virtual 
returns the best hit [19]. 
2. 1. Ligand Protein Interaction 
Drugs, which apply their biological effects by interaction with a specific target, be it an enzyme, a 
receptor, an ion channel, a nucleic acid, or any other biological macromolecule, must have three-
dimensional structure, which in the arrangement of its functional groups and in its surface properties is 
more or less complementary to a binding site. As first approximation, the followings can be concluded: 
the better the steric fit and the complementarity of the surface properties of a drug to its binding site are, 
the higher its affinity will be and the higher may be its biological activity [16]. A complication arises 
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from functionalities of biological macromolecules, typically involved in ligand-protein interactions: 
certain structural features of the ligand determine whether a compound is a substrate (having a functional 
group which is hydrolyzed, acylated, oxidized, an inhibitor (showing affinity to the binding site of an 
enzyme, but containing no a competitive receptor antagonist (having affinity to an agonist binding site, 
but an allosteric receptor antagonist (binding to a different site, see below), a functional receptor 
antagonist (having no affinity to the receptor molecule, but inhibiting the receptor response via a different 
mechanism of action), a receptor agonist (displaying intrinsic activity in addition to affinity, i.e. 
containing certain structural features which cause the receptor to respond in a certain manner), or an 
allosteric effector molecule (binding at a different site of a protein and changing its 3D structure in such a 
way that a certain property of the protein, e.g. conformational flexibility or affinity to a substrate, an 
agonist, a cofactor, or any other small or large ligand is significantly changed [17]. 
2. 2.  Protein Preparation 
Homology modelling is accomplished by using YASARA program. FASTA files of 1CET (enzyme 
downloaded from website: http/www.pdb.org), then load the 1CET pdb file to YASARA. Removed part 
of the system is not required in docking protocol (merely requires a single protein, including water if 
essential, and a ligand). Delete clq which still exists in the system (Edit> Delete> residue); select name 
clq, or has Belongs to All, and click "OK". Add hydrogen into the system using YASARA, since the 
resolution of crystal structures are not able to predict the presence of hydrogen (Edit> Add> Hydrogen to 
all). Save the file as YASARA Object (File> Save as> YASARA Object), save it as 1CET.yob. Delete the 
original ligand, leaving only the target protein alone with a pocket for simulation docking (Edit> Delete> 
Residue); Select Name clq, or has Belongs to All, click "OK", save it as protein.mol2. Pocket 
coordinates can be determined by reference to the original 3D coordinates of the ligand. Actually, there is 
only required mol2 file containing only the original ligand. 
2. 3. Ref_ligand Preparation 
After accomplishing homology modelling by using YASARA program, load the file YASARA Object 
of 1CET.yob. Next, delete the existing protein except for clq (Edit> Delete> residue) select name clq, or 
has Belongs to All, select "negate name" then click "OK". Save as ref_ligand.mol2. 
2. 4. Ligand Preparation 
Three dimensional (3D) configuration structure and initial of ligand is contributed significantly in 
quality of molecular docking simulations. Differences in decision of protonation states and tautomers of 
the ligands for SBVS input can lead to different solutions of the SBVS protocols [13] [14]. Marvin of 
ChemAxon is chosen to be applied since the application provides features to perform protonation analysis 
in desired pH as well as tautomers and conformers generations [15]. ChemAxon also provides objective 
functions that enable us to assess and choose the most plausible tautomer and the 3D configurations of the 
ligand in appropriate protonation state [15]. Gallocatecin is a ligand for docking simulation. The 
reference ligand structure is prepared in prior, using Marvin of ChemAxon by cleaned structure up in two 
dimension (2D) configurations, then followed by protonation in pH of 7.4 and subsequently generates 
ensemble 3D conformations. The results are deposited as a mol2 file to be applied further in molecular 
docking simulations using PLANTS [13]. Save as ligand.mol2.  
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2. 5. Simulation Docking PLANTS 
Open the "console" in the Co-pendrivelinux-KDE, then type the command "cp / 
mnt/win/docking_plants/PLANTS1.2 PLANTS". After appearing next command, type "chmod u + x 
PLANTS" followed by ". / PLANTS" to activate the PLANTS program. To enter the required docking 
protocol, type "cp / mnt / win / docking_plants / *. Mol2." to activate the process of docking plantsconfig 
"cp / mnt / win / docking_plants / plantsconfig." then type ". / PLANTS - bind mode ref_ligand . mol2 5 
protein.mol2 " to enter pocket into protein used as a place of its strings with the receptor. After repairs at 
ref_ligand then type "grep-Ev" # binding site definition "plantsconfig> temp_conf" continue to "grep-Ev" 
bindingsite_ "temp_conf> temp_conf2". To enable the above error message type "cat temp_conf2 
bindingsite.def> plantsconfig". After all of the preparation is completed, next step is running docking 
done by typing ". / PLANTS - plantsconfig screen mode" then you will see 10 that binds to the ligand 
conformation 1CET with different energies. For evaluation and outcome data interpretation docking, type 
"cd results /" followed by "more bestranking.csv", select from the ten conformations having the smallest 
score. 
2. 6. Virtual Screening and Retrospective Molecular Docking Simulation 
The scoring function takes a pose as input and returns a number indicating the possibility that the pose 
represents a favourable binding interaction. Most scoring functions are physics-based molecular 
mechanics force fields that estimate energy of the pose; a low (negative) energy indicates a stable system 
and thus, a likely binding interaction. An alternative approach is to derive a statistical potential for 
interactions from a large database of protein-ligand complexes, such as the Protein Data Bank, and 
evaluate the fit of the pose according to this inferred potential [18]. Based on the Molecular Docking, 
Gallocatecin has an energy (-95 396) that is smaller than mefloquine (-71.4036) to bind to 1CET. 
Decrease the level of energy, indicating that gallocatecin is easier than mefloquin to bind to the NADH 
bindingsite [6]. It means that it has a competition from the NADH as original ligand and gallocatecin to 
bind to the NADH bindingsite of lactate dehydrogenase enzyme. Lactate dehidrogenase enzyme has a 
function of giving plasmodium energy by converting glucose into energy sources for the plasmodium life. 
 
Table 1. The Value of Docking Score of 1CET 
 
 
Lactatdehydrogenase Chloroquin Mefloquin Gallocatecin 
entry_00001_conf_01                             -73.7196 -77.983 -81.1072 
entry_00002_conf_01 -72.5196 -74.0724 -81.0687 
entry_00003_conf_01                             -75.4382 
entry_00004_conf_01                             -73.6816 
-78.0037 
-78.3954 
-80.7827 
-80.9523 
entry_00005_conf_01                             -78.5536 
entry_00006_conf_01         -78.8825 
entry_00007_conf_01   -76.3153 
entry_00008_conf_01                             -81.7397 
entry_00009_conf_01                             -75.4506 
entry_000010_conf_01                           -73.6317 
-77.6062 
-78.792 
-78.924 
-73.9904 
-74.1174 
-78.0756 
-80.9569 
-81.4439 
-81.0535 
-79.948 
-81.8984 
-81.626 
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Another evidence of this argument is that gallocatecin distance is closer than mefloquine to bind to the 
NADH bindingsite. Figure 3 explains that gallocatecin has closer distance than mefloquine, this indicates 
that gallocatecin has more stable energy. 
 
 
 
 
 
 
 
 
 
 
Fig. 3.  (a) Interaction of mefloquine with enzyme lactatdehydrogenase; (b) Interaction of gallocatecin with enzyme  
lactatdehydrogenase. Mefloquine gallocatecin in 
 
 
From figure 3, it can be seen that mefloquine  is calculated from the centre or 
midpoint bindingsite NADH. It is assumed that the central pocket is the most stable bond. Closer the 
distance of the ligand to pocket, more stable bond between ligand and active amino acid. Gallocatecin is 
known having shorter distance mefloquine. 
  
 
  
 
 
 
 
 
 
 
 
 
 
Fig. 4 (a) The distance of mefloquine to NADH bindingsite; (b) The distance of gallocatecin to NADH bindingsite  
 
Moreover, NADH bindingsite, in fact, is a protein containing many amino acids; the active amino acids of 
lactate dehidrogenase are Ala 98 and Ile 119. Assuming that the distance is different between ligand and 
the receptor, the closer distance, the more stable the bond. From figure 5, we can see that the distance of 
gallocatecin bond with the amino acid Ala 98 and  while the 
distance between mefloquine It means that gallocatecin have more stable bond than 
that mefloquine to bind to lactate dehydrogenase. 
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3. Conclusions 
Gallocatecin has smaller energy than mefloquine to bind to 1CET. Thus, it can be concluded that 
gallocatecin has more potential anti-malaria activity than mefloquine, based on docking molecular. 
Acknowledgements 
We would like to thank to Faculty of Pharmacy, Gadjah Mada University, Yogyakarta for helping 
finishing this paper. 
References 
[1] Read JA, Wilkinson KW, Tranter R, Session RB, Brady RL. Chloroquine Binds in the Cofactor Binding Site of Plasmodium   
      Falciparum Lactate Dehydrogenase. J Biol Chem. 1999 Apr 9;274(15):10213-8. 
[2] Hewitt CO, Sessions RB, Dafforn TR, Holbrook JJ. Protein Engineering Tests of a Homology Model of Plasmodium Falciparum  
     Lactate Dehydrogenase. Publication Types, MeSH Terms, Substances, Secondary Source ID, Grant Support. Protein Eng.1997   
     Jan;10(1):39-44. 
[3] Alvarez Juan, Shoichet Brian. Virtual Screening in Drugs Discovery,.CRC Press, Taylor and France.2005 
[4] Schneider G., Bohm J. Virtual Screening for Bioactive Molecules. WILEY-VHC Weinheim, Germany. 2000., 49469. 
[5] Huang, N.; Shoichet, B. K.; Irwin, J. J. Benchmarking Sets for Molecular Docking. J. Med. Chem. 2006, 49,6789801 
[6] Kellenberger, E.; Foata, N.; Rognan, D. Ranking Targets in Structure Based Virtual Screening of Threedimensional Protein  
      Libraries: Methods and Problems. J. Chem. Inf. Model. 2008, 48, 101425 
[7] Kellenberger, E.; Rodrigo, J.; Muller, P.; Rognan, D. Comparative Evaluation of Eight Docking Tools for Docking and Virtual  
      Screening Accuracy. Proteins 2004, 57, 22542 
[8] Krakauer T, Li BQ, Young HA: The Favonoid Baicalin Inhibits Superantigeninduced Inflammatory Cytokines and Chemokines.  
      FEBS Letters 2001,500:52-55 
[9] Dzikowski R, Li F, Amulic B, Eisberg A, Frank M, Patel S, Wellems TE. Deitsch KW:  Mechanisms Underlying Mutually  
      Exclusive Expression of Virulence Genes by Malaria Parasites.  EMBO Rep 2007, 8:959-965 
[10]Aurrecoechea C, Brestelli J, Brunk BP, Dommer J, Fischer S, Gajria B, Gao X, Gingle A, Grant G, Harb OS, et al.: PlasmoDB:  
       A Functional Genomic Database for Malaria Parasites. Nucleic Acids Res 2008, 37:D539-543. 
[11] Snow RW, Guerra CA, Noor AM, Myint HY, Hay SI: The Global Distribution of Clinical Episodes of Plasmodium Falciparum  
       Malaria. Nature 2005, 434:214-217. 
[12]Lavstsen T, Salanti A, Jensen AT, Arnot DE, Theander TG: Subgrouping of Plasmodium Falciparum 3D7 Var Genes Based On  
       Sequence Analysis of Coding and Non-coding Regions. Malar J 2003, 2:27. 
[13] Ten Brink, T.; Exner, T. E. Influence of protonation, tautomeric, and stereoisomeric states on protein ligand docking results. J.   
       Chem. Inf. Model. 2009, 49, 153546. 
[14]Ten Brink, T.; Exner, T. E. pKa Based Protonation States and Microspecies for Protein Ligand Docking. J. Comput. Aided Mol. 
Des. 2010, 24, 93542. 
[15] ChemAxon. MarvinSketch 5.2.5.1, Budapest, 2009. 
[16] Overton, E., Studien Uber Die Narkose, Zugleich Ein Beitrag Zur Allgemeinen Pharmakologie, G. Fischer, Jena, 1901; English  
        Translation by Lipnick, R. L., ed., Studies on Narcosis Charles Ernest Overton, Chapman and Hall, London, 1991. 
[17] Purcell, W. P., Bass, G. E., and Clayton, J. M., Strategy of Drug Design. A Molecular Guide to Biological Activity, Wiley,  
        New York, 1973 
[18] Feig M, Onufriev A, Lee MS, Im W, Case DA, Brooks CL (2004). "Performance Comparison of Generalized Born and Poisson  
        Methods in the Calculation of Electrostatic Solvation Energies for Protein Structures". Journal of Computational   
        Chemistry 25 (2): 265 84 
[19] Raquel Dias and Walter Filgueira de Azevedo Jr. Molecular Docking Algorithms. Current Drug Targets, Brazil, 2008, 9, 1040- 
        1047 
 
 
 
